Supplementary Table 1 from A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer

crossref(2024)

引用 0|浏览0
暂无评分
摘要
Baseline patient and tumor characteristics by disease cohort
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要